When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

Biotechnology companies are developing novel obesity medicines to compete with blockbuster weight-loss drugs.

Maridebart cafraglutide, a novel injectable GIP receptor antagonist/GLP-1 receptor agonist, reduced body weight by ...

Holiday weight gain hits home for many come January. These days, folks making resolutions to slim down and get fit have an ...